-
New regulations in the Year 2023 for different regulatory bodies around the world
Muhammad Asim Niazi
January 23, 2024
This article will explore new regulations in countries like the United States, Europe, Japan, and Australia.
-
Lupin’s Generic Health acquires Southern Cross Pharma in Australia
expresspharma
August 02, 2021
As a part of the transaction, Generic Health will gain access to over 60 registered products having sales of over AUD 30 million.
-
Eccogene Announces Completed First-in-human of ECC0509 in Phase 1a Clinical Trial in Australia
prnasia
July 29, 2021
Eccogene, Inc., a clinical stage biopharmaceutical company focused on discovery and development of metabolic and immunologic therapeutics, announced the initiation of a Phase 1a clinical trial evaluating ECC0509, an oral inhibitor of ...
-
Italy blocks export of 250,700 AstraZeneca/Oxford Covid-19 vaccines to Australia
pharmaceutical-technology
March 08, 2021
The Italian Government has refused to authorise the export of 250,700 doses of AstraZeneca/University of Oxford’s Covid-19 vaccine to Australia.
-
Cipla Gulf expands partnership with Alvotech for commercialisation of biosimilars in Australia and New Zealand
expresspharma
March 02, 2021
Cipla has announced that it’s subsidiary, Cipla Gulf is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand.
-
Bionic Vision Technologies Advances Clinical Program With AU$1 million Medical Research Future Fund Grant
prnasia
February 22, 2021
Bionic Vision Technologies (BVT) has started work on the next phase of development for its world-leading Australian bionic eye technology thanks to a recent Australian Government grant to refine its vision processing algorithms.
-
Australia approves Pfizer-BioNTech’s Covid-19 vaccine
pharmaceutical-technology
January 26, 2021
Australia’s Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer-BioNTech Covid-19 vaccine for use in people aged 16 years and above.
-
Australia brings forward COVID-19 vaccine roll-out to early March
expresspharma
January 07, 2021
The government plans to complete a mass inoculation programme for its 25 million citizens by the end of this year.
-
Australia invests AUSD 4 mn for research with India on COVID-19
expresspharma
December 14, 2020
Apart from new technologies for early detection of COVID-19, the researchers are focusing on the longer-term effects of the virus on the heart and lungs of patients who have recovered.
-
Australia to acquire 40 million doses of Novavax Covid-19 vaccine
pharmaceutical-technology
November 06, 2020
Novavax has signed a non-binding heads of terms document with the Australian Government to supply 40 million doses of its Covid-19 vaccine candidate, NVX-CoV2373.